Standout Papers

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 count... 2004 2026 2011 2018 7.8k
  1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study (2004)
    Salim Yusuf, Steven Hawken et al. The Lancet
  2. Clopidogrel with or without Omeprazole in Coronary Artery Disease (2010)
    Deepak L. Bhatt, Byron Cryer et al. New England Journal of Medicine
  3. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial (2012)
    Stefan H. Hohnloser, Ziad Hijazi et al. European Heart Journal

Immediate Impact

2 from Science/Nature 100 standout
Sub-graph 1 of 16

Citing Papers

Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
2023 Standout
Diagnosis and Treatment of Acute Coronary Syndromes
2022 Standout
14 intermediate papers

Works of Fernando Laņas being referenced

Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Fernando Laņas 6261 2871 1379 2430 188 12.8k
Cheryl Dennison Himmelfarb 9983 3459 2221 3509 235 21.5k
Julia Hippisley–Cox 3380 2769 2267 1985 224 15.8k
Ira S. Ockene 4582 2749 1732 1810 179 15.8k
Robert Clarke 2876 4205 1539 2014 206 16.4k
Jonathan Emberson 6146 7590 2007 3963 133 20.3k
Jean Ferrières 6358 3845 1912 2819 518 15.0k
Sarah Lewington 7945 3515 2096 3375 123 19.3k
Eva Lonn 8002 3093 1389 2497 191 15.5k
Jesper Hallas 3373 3192 2272 1039 467 16.8k
Laurence Sperling 3666 2202 1014 1899 255 9.0k

All Works

Loading papers...

Rankless by CCL
2026